Print ERC_15_4_cover

6,101 views

Published on

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
6,101
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Print ERC_15_4_cover

  1. 1. 1351-0088(200812)15:4;1-T
  2. 2. Announcements Announcements 52nd Symposium of the German Endocrine Society DGE 4–7 March 2009, Giessen, Germany. Contact: Reinhard G Bretzel, Third Medical Department, University Hospotal Giessen and Marburg, Rodthohl 6, D-35392, 35392, Joint Symposium Obesity and Metabolic Diseases Special Germany (Tel: +49 (0) 641 994 2750; Fax: +49 (0) 641 994 Interest Group and Clinical Pharmacology Section 17 2759; Email: reinhard.bretzel@uniklinikum-giessen.de; December 2008, Brighton, UK. Contact: Sarah Mackay, Web: http://www.giessen2009.de) British Pharmacological Society (Email: sm@bps.ac.uk) 6th Annual ENETS Conference 5–7 March 2009, Granada, Fertility 2009 7–9 January 2009, Edinburgh, UK. Contact: Spain. Contact: ENETS (Email: enets.office@charite.de; Jessica Canfor, Profile Productions Ltd, Northumberland Web: http://www.neuroendocrine.net/rel/) House, 11 The Pavement, Popes Lane, London, W5 4NG, UK (Tel: 020 8832 7311; Fax: 020 8832 7301; Email: ISCD 15th Annual Meeting 11–14 March 2009, Orlando, USA. fertility@profileproductions.co.uk; Web: Contact: International Society for Clinical Densitometry http://www.fertility2009.org/) (Tel: 860 586 7563; Fax: 860 586 7550; Email: Type 2 Diabetes and Insulin Resistance 20–25 January iscd@iscd.org; Web: http://www.iscd.org/) 2009, Banff, Canada. Contact: Keystone symposia (Email: info@keystonesymposia.org; Diabetes UK Annual Professional Conference 2009 11–13 Web: http://www.keystonesymposia.org/ March 2009, Glasgow, Scotland. Contact: Conferences Meetings/ViewMeetings.cfm?MeetingID=996) Team, Macleod House, 10 Parkway, London, NW1 7AA, UK (Tel: 0207 424 1000; Fax: 0207 424 1081; Email: Obesity: Novel Aspects of the Regulation of Body Weight conferences@diabetes.org.uk; Web: 20–25 January 2009, Banff, Canada. Contact: Keystone http://www.diabetes.org.uk/apc2009) symposia (Email: info@keystonesymposia.org; Web: http://www.keystonesymposia.org/ Society for Endocrinology BES 2009 16–19 March 2009, Meetings/ViewMeetings.cfm?MeetingID=997) Harrogate, UK. Contact: Shirine Borbor, Society for Endocrinology, 22 Apex Court, Woodlands, Bradley Stoke, Expanding Boundaries of Endocrinology 27 January 2009, Bristol, BS32 4JT, UK (Tel: +44 (0)1454 642 210; Fax: +44 London, UK. Contact: Jo Summers, Royal College of (0)1454 642 222; Email: conferences@endocrinology.org; Physicians, London, UK (Email: Web: http://www.endocrinology.org/meetings/2009/ conferences@rcplondon.ac.uk; Web: sfebes2009/) http://www.rcplondon.ac.uk/event/details.aspx?e=1379) Ion Channels as Therapeutic Targets 2009 5–6 February ECCEO 9 Athens 2009 18–21 March 2009, Athens, Greece. 2009, Novartis Horsham Research Centre, Horsham, UK. Contact: YP Communication, Boulevard G. Kleyer, 108, Contact: BPS (Email: meetings@bps.ac.uk; Web: ` B-4000 Liege, Belgium (Tel: +32 (0)4 254 12 25; Fax: +32 http://www.bps.ac.uk) (0)4 254 12 90; Email: yolande@piettecommunication.- com; Web: http://www.ecceo9.org/index.html) Course in Advanced Endocrinology 6–8 February 2009, Grand Copthorne Waterfront Hotel, Singapore. Contact: 2nd Joint Meeting of the International Bone and Mineral Sarah Ten (Email: mice2@themeetinglab.com; Web: Society and the Australian & New Zealand Bone & http://www.endometab.com/index.shtml) Mineral Society 21–25 March 2009, Sydney, Australia. Contact: International Bone and Mineral Society (Web: 5th Asia-Oceana Conference on Obesity 6–8 February 2009, http://www.ibms2009.com/) Mumbai, India. Contact: Mr Euan Woodward, Obesity International Trading Ltd, 231 North Gower Street, London, Cell Death Pathways 22–27 March 2009, Whistler, Canada. NW1 2NR, UK (Tel: +44 (0) 20 7691 1900; Email: Contact: Keystone Symposia (Email: info@keystone- ewoodward@iaso.org; Web: symposia.org; Web: http://www.keystonesymposia. http://aiaaro.com/aiaaro2009/) org/Meetings/ViewMeetings.cfm?MeetingID=970) Society for Endocrinology Clinical Cases Meeting in European Association for the Study of Obesity Bjorntorp association with the RSM 10 February 2009, London, Symposium 24–27 March 2009, Prague, Czech Republic. UK. Contact: Conference team (Email: conferences Contact: EASO, 231 North Gower Street, London, NW1 @endocrinology.org; Web: 2NR, UK (Email: enquiries@easo.org; Web: http://www.endocrinology.org/meetings/2009/cc2009/) http://www.easo.org/) Complications of Diabetes and Obesity 24 February–1 March 2009, Vancouver, Canada. Contact: Keystone 3rd International Meeting on Skeletal Endocrinology 27 symposia (Email: info@keystonesymposia.org; Web: March 2009, University of Brescia, Italy. Contact: http://www.keystonesymposia.org/ Secretariat (Email: skeletal@euroconventions.it; Web: Meetings/ViewMeetings.cfm?MeetingID=998) http://www.skeletal-endocrinology.org/presentazione.asp)
  3. 3. Announcements 43rd Annual European Society for Clinical Investigation, American Association of Endocrine Surgeons Annual Frankfurt 1–4 April 2009, Frankfurt / Main, Germany. Meeting 2009 2–5 May 2009, Madison, USA. Contact: Contact: Nicola Bock-Schildbach, Congress & Promotion, AAES (Email: cartyse@upmc.edu; Web: ¨ Amselweg 7, Konigstein 61462, Germany (Tel: +49 (0) http://www.endocrinesurgery.org/mtgs/ 6174/933595; Fax: +49 (0) 6174/933596; Email: Bock- future_meetings.cfm) Schildbach@esci2009.com; Web: http://www.esci2009.com) 17th European Congress on Obesity - ECO 2009 6–9 May 2009, Amsterdam, Netherlands. Contact: ECO 2009 IASO Stock Conference: Obesity and Inflammation 3–6 (Email: eco2009@easoobesity.org; Web: April 2009, Cairns, Australia. Contact: IASO (Tel: +44 (0) http://www.easoobesity.org/eco2009/) 207 691 1900; Email: stock@iaso.org; Web: http://www.iaso.org/stock2009.asp) American Association of Clinical Endocrinologists 18th Annual Meeting and Clinical Congress 13–17 May ASBMB 2009 Annual Meeting 18–22 April 2009, New 2009, Houston, USA. Contact: AACE, 245 Riverside Ave, Orleans, USA. Contact: ASBMB, ASBMB Meetings Office, Suite 200, Jacksonville, Florida, 32202, USA 9650 Rockville Pike, Bethesda, MD, USA, 20814-3996 (Tel: 904-353-7878; Email: asanders@aace.com; Web: (Email: meetings@asbmb.org; Web: https://www.aace.com/meetings/ http://www.asbmb.org/Page.aspx?id=146) calendar/calendar.php) British Neuroscience Association 20th National Meeting - 3rd IVI International Congress 14–16 May 2009, Madrid, Liverpool 2009 19–22 April 2009, Liverpool, UK. Contact: Spain. Contact: comtecMED (Email: Info@Comtecmed. British Neuroscience Association (Email: bna2009@liv. com; Web: http://www.comtecmed.com/ivi/2009/ ac.uk; Web: http://www.bna.org.uk/bna2009/) Default.aspx) 3rd Focused Meeting Cell Signalling 20–21 April 2009, The 8th European Congress on Menopause 16–20 May 2009, University of Leicester, Leicester, UK. Contact: BPS London, UK. Contact: Kenes International, 1-3 rue de (Email: meetings@bps.ac.uk; Web: http://www.bps.ac.uk) Chantepoulet, CH-1211 Geneva, Switzerland (Email: emas@kenes.com; Web: http://www.kenes.com/emas- 11th European Congress of Endocrinology 25–29 April congress/) 2009, Istanbul, Turkey. Contact: European Society of Endocrinology, c/o Sezen Elagoz, TeamCon Congress 36th European Symposium on Calcified Tissues 23–27 May Services Worldwide, Halaskargazi Caddesi Alp Palas Apt. 2009, Vienna, Austria. Contact: Amanda Sherwood, PO No:79/1, 34371 Harbiye, Istanbul, (Tel: +90 212 343 80 03; Box 337, Patchway, Bristol, BS32 4ZR, UK (Tel: +44 (0) Fax: +90 212 343 80 23; Email: secretariat@ece2009.com; 1454 610255; Fax: +44 (0) 1454 610255; Email: Web: http://www.ece2009.com/) admin@ectsoc.org; Web: http://www.ectsoc.org)
  4. 4. Author guidelines Author guidelines for Endocrine- Please provide files no larger than 15 MB via email to Related Cancer erc@endocrinology.org, or on PC (DOS)-formatted disks if possible (this option is also available on many The scope of the journal Macintosh systems). The preferred word processing All types of basic, clinical and experimental investigation format is RTF, but files produced using other packages and observation concerning endocrine-related cancers in can be translated. Please provide printed copies of all human and animal subjects. files when supplying electronic versions. The disk/email should carry the text, references, figure Types of papers legends and tables. Diagrams and photographs should Reviews (and original research papers of exceptional be supplied as separate paper copies (and electronic files quality) are considered. if possible). Submission of papers Reviews Please submit online using the Manuscript Central Title page system. Guidelines for this can be found at This should contain the complete title (please limit this to www.endocrinology.org/sfe/onlsub.htm. If you are a maximum of 20 words), names of all authors, full unable to submit online please send your manuscript and addresses of all institutions (the address of the laboratory a disk containing all files to the Editor-in-Chief, where the work was carried out should be given first) and Endocrine-Related Cancer, 22 Apex Court, Woodlands, a short title for page headings. Bradley Stoke, Bristol BS32 4JT, UK. Tel: C44-(0)1454-42220; Fax: C44-(0)1454-642222. Abstract There is no charge for submitting papers nor will there be The abstract (which should be no more than 5% of the any subsequent page charges. length of the paper) should summarize the main findings General instructions of the paper and the conclusions reached. If submitting by post, three copies of the manuscript, References three sets of halftone figures and a disk containing all files In the text, references should be cited by giving the name are required. Only one set of line drawings needs to be of of the first author et al. where there are more than two publishable quality; the others may be photocopies. authors. In the reference list all authors should be given When submitting a paper for consideration, authors and the titles of the papers and the journals should be must give written assurance that the work has not been, written in full. Examples of reference style are as follows: and will not be, submitted for publication elsewhere until the journal has reached a decision on whether to publish See RH, Calvo D, Shi Y, Kawa H, Luke MP & Yuan Z the paper. If rejected the authors are free to submit 2001 Stimulation of p300-mediated transcription by the elsewhere; if accepted the assurance automatically kinase MEKK1. Journal of Biological Chemistry 276 extends indefinitely. It will be assumed that submitted 16310–16317. manuscripts carry the approval of all the authors. Authors Harvey SS 1975 Hypnotics and sedatives. The are required to acknowledge all of the major sources of barbiturates. In Pharmacological Basis of Therapeutics, funding relevant to the research reported in the edn 5, pp 102–123. Eds LS Goodman & A Gilman. New Acknowledgements section and to declare that there is York: Macmillan Publishing Co. either: (a) no conflict of interest that would prejudice its impartiality; or (b) a potential conflict of interest that is fully Endocrine-Related Cancer reference style for End Note declared within the text of the article. (version 3 and above) is available from the online author Manuscripts must be in English and spelling should guidelines. follow The Shorter Oxford English Dictionary or Merriam– Webster’s Collegiate Dictionary. All abbreviations must Please note that papers with incorrectly be defined. Manuscripts should be printed double- formatted references will be returned and the spaced, preferably in a Times font, and with a size of at acceptance date changed to the date of receipt of least 10 point. the correctly formatted paper. To expedite refereeing the author should provide duplicate copies of papers quoted as ‘In Press’, Tables particularly those concerned with methodology. To facilitate the rapid processing of their paper authors Tables should have full and informative headings and should also provide a fax number and an email address. should be supplied electronically and as hard copy on separate pages. Table columns should be set up using Use of computer disks simple tabs rather than specialised table layouts. If your paper is accepted for publication, or you are asked Figures to revise, a word processor file for your paper and high resolution figures (see Figures section below) will be General information requested (the PDF files used for online peer review are Three-dimensional graphs to show two-dimensional data not suitable for typesetting). should be avoided and photo- and electronmicrographs www.endocrinology-journals.org
  5. 5. Author guidelines should contain scale bars. The cost of colour Abstract, Introduction, Materials and methods, Results, reproduction over and above that for black and white Discussion and References. will be charged to authors. This must be paid by credit card before publication. Please see colour charges form Commentaries at www.endocrinology.org/sfe/colourack.pdf. Please The editor reserves the right to invite commentaries or avoid grey or dotted backgrounds in all figures, as these critiques on articles accepted for publication. do not reproduce well. Legends should enable the reader to understand the information contained in figures Ethics of experimental procedures on without reference to the text. human subjects Manuscripts must contain a statement that consent has Paper copies been obtained from each patient or subject after full These should be provided even when electronic copies explanation of the purpose and nature of all procedures are also supplied and should be numbered on separate used. It must be stated that the investigation was pages, bearing the first author’s name. One set of line approved by the local ethical committee, functioning drawings should be good quality originals, e.g. from a according to the 3rd edition of the Guidelines on the laser printer (not photocopies). There is no need to Practice of Ethical Committees in Medical Research issued by the Royal College of Physicians of London photograph originals of line drawings. (11 St Andrew’s Place, London NW1 4LE, UK; Tel: C44 (0) 207 935 1174; Fax C44 (0) 207 7486 4514; Electronic copies (accepted papers only) Email: publications@rcplondon.ac.uk; Once the article has been accepted we require the Web: www.rcplondon.ac.uk). Copies of the MRC following (as the 1 MB PDF file used for refereeing would recommendations can be obtained from the Medical be unsuitable for printing): Research Council, 20 Park Crescent, London W1B 1AL, UK (Tel: C44 (0) 20 7636 5422; † The text of the paper to be submitted as separate RTF Fax: C44 (0) 20 7636 6179) or via www.mrc.ac.uk. file. Use of living animals † The tables should be submitted in word format as a separate file. All papers describing experiments on animals should † For figures the formats required are conform with The UFAW Handbook on the Care and B The line figures (graphs, bar diagrams) should also Management of Laboratory Animals, 7th edition, be submitted as separated EPS (resolution greater published by the Universities Federation for Animal than 300 dpi) or TIFFS (resolution greter than Welfare, The Old School, Brewhouse Hill, 1000 dpi). Wheathampstead, Herts AL4 8AN, UK B Scanned images or images from digital capture (Tel: C44 (0) 1582 831818; Fax: C44 (0) 1582 831414; devices (gels, confocal microscopy figures) should Web: http://www.ufaw.org.uk/pubs.htm#lab). Papers be submitted as TIFF file (resolution greater than which do not conform with these guidelines or with UK 300 dpi): colour images should be saved in CMYK legal requirements cannot be accepted. format and mono images should be saved in Copyright greyscale format. You can find details of how to create high resolution PDFs Articles are considered on the understanding that, if they and illustrations in PowerPoint www.endocrinology- are accepted for publication, the entire copyright shall journals.org/misc/artwork. pass to the Society for Endocrinology. All authors are asked to sign a copyright agreement to this effect. To facilitate the processing of your manuscript please Use of statistical analysis complete the form printed on the following page and To enable the reader to judge the validity of results, the submit it with your paper. Requests for permission to number of experimental subjects used (n), and the extent reproduce any part of papers published in Endocrine- of independent experimental repetition from which data Related Cancer should be addressed to the Permissions are taken, should be stated. Authors should, where Secretary (editorial@endocrinology.org). possible, support their conclusions with appropriate Self-archiving:institutional and other online statistical analysis. The test used must be described concisely and the results presented clearly. The term repositories ‘significant’ should not be used without supporting You may archive your final accepted article onto online evidence from statistical analysis and the P value used to repositories, subject to various conditions set out in the determine significance must be stated. Society’s policy (www.endocrinology- journals.org/misc/archiving_policy.dtl). Original research papers The main emphasis of the journal is on review articles but Offprints original articles may be accepted if of exceptional quality. A free PDF will be emailed to the corresponding author. The article should conform with the requirements for Offprints can be ordered on the form accompanying the reviews and the text should generally follow the format: proof. www.endocrinology-journals.org
  6. 6. Large global Endocrine-Related Cancer readership This established journal offers a global forum for all types of basic, clinical and experimental investigation and observation concerning endocrine-related cancer in human and animal subjects. † No page or reviewing charges www.try-erc.org † Cited in Current Contents with free access to Advanced Abstracts † High impact factor: 5.193 and Accepted Preprints. † High circulation HTML and PDF full text available at subscribing institutions How to submit your paper Review articles (and original research papers of separate pages. Please supply glossy originals of exceptional quality) are considered. To submit any photographs, and include scale bars on online using the Manuscript Central system go to micrographs. Line figures should be supplied as www.endocrinology.org/sfe/onlsub.htm or send laser-printed output or equivalent; avoid grey or five copies of your manuscript (including figures dotted shading. References should be listed and tables) to the Editor, Endocrine-Related alphabetically and should include the full article Cancer, 22 Apex Court, Woodlands, Bradley and journal titles. They should be cited by name and Stoke, Bristol BS32 4JT, UK. date in the text. American and British spelling are To ease our handling of your paper, please equally acceptable. All articles should include supply copies of any article cited as ‘in press’. abstracts. Tables and illustrations should be numbered and on Subscribe to Endocrine-Related Cancer Contains important review articles – All papers peer-reviewed – Reports conference and symposium proceedings – Global coverage and editorial board ISSN 1351-0088 (print) ISSN 1479-6821 (online) (Quarterly) Editor: Dr J A Fagin .................................................................................................... Order form Please enter my 2009 subscription to Endocrine-Related Cancer at , The personal price of = 350 (Europe)/$440 (N&S America)/£233 (UK & Rest of the World) C , The printConline institutional price of= 1255 (Europe)/$1595 (N&S America)/£850 (UK & Rest of the World) C , The online only institutional price of= 1205 (Europe)/$1520 (N&S America)/£815 (UK & Rest of the World) C , ERCCJOECJME: The printConline institutional price of = 2725 (Europe)/$3530 (N&S America)/£1820 C (UK & Rest of the World) , Send me a proforma invoice , Charge my Visa/Access/Mastercard (Number) Expiry date Name Address Signature Date If paying by credit card, please ensure you include your address where your credit card bills are sent, if different from above. Please return this form to Society of Endocrinology, c/o Portland Press, Commerce Way, Colchester, CO2 8HP (Tel: C44-1206-796351; Fax: C44-1206-799331; Email: sales@endocrinology.org). A Society of Endocrinology publication
  7. 7. Author guidelines Assignment of copyright to the Society for Endocrinology In order to publish your article we need your agreement in writing. Please take a moment to read the terms of this assignment, sign the form and return it to us as quickly as possible. Journal: Endocrine-Related Cancer Title of article ....................................................................................................................................................................................................................... ............................................................................................................................................................................................................................................... Name(s) of author(s)............................................................................................................................................................................................................. ............................................................................................................................................................................................................................................... ............................................................................................................................................................................................................................................... Name of copyright owner, if not author(s) .......................................................................................................................................................................... Address of above copyright owner (if applicable) .............................................................................................................................................................. ............................................................................................................................................................................................................................................... † By signing this form, you (the author(s) or other copyright owner, such as your employer) agree to transfer to us (the Society for Endocrinology, the publisher) the copyright in the above article, thus giving us the exclusive right to reproduce, distribute and broadcast the above article (including the abstract) ourselves throughout the world in printed, electronic or anyother medium, and in turn to authorize others (including Reproduction Rights Organisations such as the Copyright Licensing Agency and the Copyright Clearance Center) to do the same. You agree that we may publish your article in the journal named above, and that we may sell or distribute it within the journal, on its own, or with other related material. † You confirm that all of the named authors contributed substantially to the article, and agree to take public responsibility for the validity of its content. You also confirm that all major sources of funding have been acknowledged in the text of the article, and that there is either (a) no conflict of interest that would prejudice its impartiality, or (b) a potential conflict of interest that is fully declared within the text of the article. † You promise that the article is your original work, has not previously been published, and is not currently under consideration by another journal. If it contains material (such as a previously published illustration) which is someone else’s copyright, you promise that you have obtained the unrestricted permission of the copyright owner (please attach evidence of this) and that the material is clearly identified and acknowledged within the text. You also promise that the article does not, to the best of your knowledge, contain anything which is libellous, illegal, or infringes anyone’s copyright or other rights. † We promise that we will respect your rights as the author(s). That is, we will make sure that your name(s) is/are always clearly associated with the article and, while you do allow us to make necessary editorial changes, we will not make any substantial alteration to your article without consulting you. We will have your article reviewed by impartial referees, and will let you know the outcome as quickly as we can. If the article is accepted, we undertake to publish it as soon as we reasonably can. If it is rejected, this agreement is automatically cancelled and all the rights come back to you. † We will do everything we reasonably can to maximize the visibility of the journal, and of your article within it. We will mount your article’s abstract on our web site within a few days of acceptance. On final publication, we will send you an Acrobat PDF file of your article in its final published form. You are free to use it in all the ways described in the next paragraph. We will also send you an order form to enable you to buy offprints. † You remain free to use your own article for the internal educational or research purposes of your own institution or company and to use it, in whole or in part, as the basis for your own further research or spoken presentations, provided you neither sell it nor encourage others to infringe our copyright. † You may self archive or otherwise deposit your final accepted manuscript on freely available institutional or other online repositories (such as NIH’s PubMed Central), provided (i) the version deposited is the manuscript, as finally accepted by the relevant journal but prior to copy editing and page formatting; (ii) you ensure that it will not become publicly available until 12 months after publication in the journal; (iii) the manuscript made available in this way includes the Society’s standard disclaimer (see http://www.endocrinology- journals.org/misc/archiving_poliy.dtl) Signature(s) of Author(s)......................................................................................................................... Date .............................................. ................................................................................................................................................................. Date .............................................. ................................................................................................................................................................. Date .............................................. ................................................................................................................................................................. Date .............................................. Note: every named author must sign this form, or a copy of it Signature of Copyright Owner, if different............................................................................................. Date .............................................. Please return this form by post or fax to the Society for Endocrinology, 22 Apex Court, Woodlands, Bradley Stoke, Bristol BS32 4JT, UK (Fax +44(0)1454 642222). By submitting your article to this journal, you agree that we may store your details on its manuscript database. We may occasionally use these details to send you information about services we think will interest you. We will never pass your details to any other organization. If you would prefer not to receive any mailings from us, please write to us at the above address. www.endocrinology-journals.org
  8. 8. Volume 15 Endocrine – Related ISSN 1351–0088 (print) ISSN 1479–6821 (online) Cancer Editor-in-Chief J A Fagin New York, NY, USA Associate Editors C L Clarke A B Grossman K Knudsen Sydney, Australia London, UK Philadelphia, PA, USA Founding Editor V H T James London, UK Editorial Board J Adamski S L Asa X Bertagna Munich, Germany Toronto, Canada Paris, France N Bundred C Coombes Z Culig Manchester, UK London, UK Innsbruck, Austria W E Farrell W L Gerald A Heaney Keele, UK New York, NY, USA Los Angeles, CA, USA W W de Herder J T Isaacs E Liu Rotterdam, Netherlands Baltimore, MD, USA Singapore ´ S Menard M Motta E Musgrove Milan, Italy Milan, Italy Darlinghurst, NSW, Australia R Nicholson N Normanno K Pacak Cardiff, UK Naples, Italy Bethesda, MD, USA F Pacini M Ringel B Robinson Siena, Italy Columbus, OH, USA Sydney, Australia D S Salomon M Santoro J W Simons Bethesda, MD, USA Naples, Italy Baltimore, MD, USA C Stratakis W Tilley R Vigneri Bethesda, MD, USA Adelaide, Australia Catania, Italy M van de Vijver J Wimalsena Amsterdam, Netherlands Knoxville, TN, USA
  9. 9. Endocrine-Related Cancer is published by the Society for Endocrinology (Limited by Guarantee). The agent for distribution is Portland Press, PO Box 32, Commerce Way, Whitehall Industrial Estate, Colchester CO2 8HP, UK. Copyright q2008 by the Society for Endocrinology. Typeset and printed in Europe by the Alden Group, Oxfordshire, UK Printed on acid-free paper.
  10. 10. 2008 Endocrine – Related Volume 15 Cancer ISSN 1351–0088 (print) ISSN 1479–6821 (online) Volume contents Number 1 $ March 2008 Modulation of proteomic profile in H295R A Stigliano, L Cerquetti, M Borro, 1–10 adrenocortical cell line induced by mitotane G Gentile, B Bucci, S Misiti, P Piergrossi, E Brunetti, M Simmaco & V Toscano The emergence of DNA methylation as a T M Murphy, A S Perry 11–25 key modulator of aberrant cell death in & M Lawler prostate cancer Aromatase inhibitors for breast cancer: Riccardo Ponzone, Paola Mininanni, 27–36 different structures, same effects? Elisa Cassina, Francesca Pastorino & Piero Sismondi Bone metastases from differentiated thyroid ` M M Muresan, P Olivier, J Leclere, 37–49 carcinoma F Sirveaux, L Brunaud, M Klein, R Zarnegar & G Weryha Thyroid stem cells: lessons from normal Dolly Thomas, Susan Friedman & 51–58 development and thyroid cancer Reigh-Yi Lin Transforming growth factor-b signalling Eric Glasgow & Lopa Mishra 59–72 and ubiquitinators in cancer Menopausal symptoms and adjuvant P Hadji 73–90 therapy-associated adverse events Arachidonic acid modulates the crosstalk Adriano Angelucci, 91–100 between prostate carcinoma and bone Stefania Garofalo, Silvia Speca, stromal cells Antonella Bovadilla, Giovanni Luca Gravina, Paola Muzi, Carlo Vicentini & Mauro Bologna
  11. 11. Fibroblast growth factor receptor 4 predicts Danielle Meijer, Anieta M Sieuwerts, 101–111 failure on tamoxifen therapy in patients Maxime P Look, Ton van Agthoven, with recurrent breast cancer John A Foekens & Lambert C J Dorssers Intratumoral concentration of sex steroids Rie Shibuya, Takashi Suzuki, 113–124 and expression of sex steroid-producing Yasuhiro Miki, Kimako Yoshida, enzymes in ductal carcinoma in situ of Takuya Moriya, Katsuhiko Ono, human breast Jun-ichi Akahira, Takanori Ishida, Hisashi Hirakawa, Dean B Evans & Hironobu Sasano ABCC11 expression is regulated by ` Mylene Honorat, Aurelia Mesnier, 125–138 estrogen in MCF7 cells, correlated with ´ ˆ Julie Vendrell, Jerome Guitton, estrogen receptor a expression in Ivan Bieche, Rosette Lidereau, postmenopausal breast tumors and Gary D Kruh, Charles Dumontet, overexpressed in tamoxifen-resistant breast Pascale Cohen & Lea Payen cancer cells Enhanced expression of aromatase in Hoo Kyun Choi, Sang Hee Roh, 139–147 p53-inactivated mammary epithelial cells Hyung Gyoon Kim, Eun Hee Han, Hye Gwang Jeong & Keon Wook Kang A novel vaccine targeting gastrin-releasing Wu Guojun, Guo Wei, 149–159 peptide: efficient inhibition of breast cancer Ouyan Kedong, He Yi, Xie Yanfei, growth in vivo Chen Qingmei, Zhang Yankai, Wu Jie, Fan Hao, Li Taiming, Liu Jingjing & Cao Rongyue Global gene expression profiles induced by Ramiro Dip, Sarah Lenz, 161–173 phytoestrogens in human breast cancer cells Jean-Philippe Antignac, Bruno Le Bizec, Hans Gmuender & Hanspeter Naegeli Cytological Ki-67 in pancreatic endocrine Cecilia Piani, Giulia M Franchi, 175–181 tumours: an opportunity for pre-operative Chiara Cappelletti, Marina Scavini, grading Luca Albarello, Alessandro Zerbi, Paolo Giorgio Arcidiacono, Emanuele Bosi & Marco F Manzoni Association of the T1799A BRAF mutation Yangang Wang, Meiju Ji, 183–190 with tumor extrathyroidal invasion, higher Wei Wang, Zhimin Miao, peripheral platelet counts, and Peng Hou, Xinyan Chen, Feng Xu, overexpression of platelet-derived growth Guangwu Zhu, Xianlu Sun, factor-B in papillary thyroid cancer Yujun Li, Steven Condouris, Dingxie Liu, Shengli Yan, JiePan & Mingzhao Xing
  12. 12. BRAF(V600E) mutation and the biology of F Frasca, C Nucera, G Pellegriti, 191–205 papillary thyroid cancer P Gangemi, M Attard, M Stella, M Loda, V Vella, C Giordano, F Trimarchi, E Mazzon, A Belfiore & R Vigneri Familial non-medullary thyroid carcinoma Branca M Cavaco, Pedro F Batista, 207–215 (FNMTC): analysis of fPTC/PRN, NMTC1, Carmo Martins, Ana Banito, MNG1 and TCO susceptibility loci and ´ Francisco do Rosario, identification of somatic BRAF and RAS Edward Limbert, mutations ´ Luıs G Sobrinho & Valeriano Leite Deregulation of anti-Mullerian Nader Hussein, JieLi Lu, 217–227 hormone/BMP and transforming growth ` Huguette Casse, Sandra Fontaniere, factor-b pathways in Leydig cell lesions Anne-Marie Morera, developed in male heterozygous multiple ´ Severine Mazaud Guittot, endocrine neoplasia type 1 mutant mice Alain Calender, Nathalie Di Clemente & Chang X Zhang Somatostatin-producing neuroendocrine Nele Garbrecht, Martin Anlauf, 229–241 tumors of the duodenum and pancreas: Anja Schmitt, Tobias Henopp, incidence, types, biological behavior, Bence Sipos, Andreas Raffel, association with inherited syndromes, and Claus F Eisenberger, functional activity Wolfram T Knoefel, Marianne Pavel, Christian Fottner, Thomas J Musholt, Anja Rinke, Rudolf Arnold, Uta Berndt, Ursula ¨ Plockinger, Bertram Wiedenmann, Holger Moch, Philipp U Heitz, Paul Komminoth, Aurel Perren & ¨ ¨ Gunter Kloppel Defining molecular classifications and Eva-Maria Duerr, Yusuke Mizukami, 243–256 targets in gastroenteropancreatic Aylwin Ng, Ramnik J Xavier, neuroendocrine tumors through DNA Hirotoshi Kikuchi, microarray analysis Vikram Deshpande, Andrew L Warshaw, Jonathan Glickman, Matthew H Kulke & Daniel C Chung Antitumor activity of rapamycin and Amy Moreno, Argun Akcakanat, 257–266 octreotide as single agents or in Mark F Munsell, Alpana Soni, combination in neuroendocrine tumors James C Yao & Funda Meric-Bernstam
  13. 13. Parathyroid tumor development involves H-C Jennifer Shen, 267–275 deregulation of homeobox genes Jennifer E Rosen, Lauren M Yang, Sharon A Savage, A Lee Burns, Carmen M Mateo, Sunita K Agarwal, Settara C Chandrasekharappa, Allen M Spiegel, Francis S Collins, Stephen J Marx & Steven K Libutti Anti-cancer actions of a recombinant ¨ M A Redondo-Muller, 277–288 antibody (R6313/G2) against the M Stevanovic-Walker, S Barker, angiotensin II AT1 receptor J R Puddefoot & G P Vinson Adiponectin receptor expression is elevated Catherine J Williams, 289–299 in colorectal carcinomas but not in Nicholas Mitsiades, gastrointestinal stromal tumors Elias Sozopoulos, Alex Hsi, Alicja Wolk, Artemissia-Phoebe Nifli, Sofia Tseleni-Balafouta & Christos S Mantzoros Characterization of gastrin–cholecystokinin Martine J Hollestelle, 301–309 2 receptor interaction in relation to c-fos Peter Timmerman, Rob H Meloen & induction ¨ Jo W M Hoppener Role of positron emission tomography and ´ˇ Tomas Zelinka, 311–323 bone scintigraphy in the evaluation of bone Henri J L M Timmers, involvement in metastatic Anna Kozupa, Clara C Chen, pheochromocytoma and paraganglioma: Jorge A Carrasquillo, specific implications for succinate James C Reynolds, dehydrogenase enzyme subunit B gene Alexander Ling, Graeme Eisenhofer, mutations ´ ´ Ivica Lazurova, Karen T Adams, Millie A Whatley, Jir´ Widimsky Jr ˇı ´ & Karel Pacak The insulin receptor: a new anticancer V Costa, D Foti, F Paonessa, 325–335 target for peroxisome proliferator-activated E Chiefari, L Palaia, G Brunetti, receptor-g (PPARg) and thiazolidinedione- E Gulletta, A Fusco & A Brunetti PPARg agonists Gastric endocrine tumors type I: treatment D Campana, F Nori, R Pezzilli, 337–342 with long-acting somatostatin analogs L Piscitelli, D Santini, E Brocchi, R Corinaldesi & P Tomassetti Over-expression of ERBB-2 was more WenQi Yuan, WeiQinq Wang, 343–350 frequently detected in malignant than Bin Cui, TingWei Su, Yan Ge, benign pheochromocytomas by multiplex Lei Jiang, WeiWei Zhou & ligation-dependent probe amplification and Guang Ning immunohistochemistry Roles of estrogen receptor a and b in Jian Teng, Zun-Yi Wang, 351–364 modulating urothelial cell proliferation David F Jarrard & Dale E Bjorling www.endocrinology-journals.org
  14. 14. Erratum 365–366 Announcements Author Guidelines Number 2 $ June 2008 Signal transducer and activator of Shyh-Han Tan & Marja T 367–390 transcription 5A/B in prostate and breast Nevalainen cancers Endocannabinoids in endocrine and related Maurizio Bifulco, Anna Maria 391–408 tumours Malfitano, Simona Pisanti & Chiara Laezza Pancreatic endocrine neoplasms: Thorvardur R Halfdanarson, 409–427 epidemiology and prognosis of pancreatic Joseph Rubin, Michael B Farnell, endocrine tumors Clive S Grant & Gloria M Petersen Analysis of single nucleotide Alberto Ferlin, Manuel Pengo, 429–437 polymorphisms of FSH receptor gene Riccardo Selice, Luigi Salmaso, suggests association with testicular cancer Andrea Garolla & Carlo Foresta susceptibility Patterns and changes in gene expression Vera Cappelletti, Manuela Gariboldi, 439–449 following neo-adjuvant anti-estrogen Loris De Cecco, Sara Toffanin, treatment in estrogen receptor-positive James F Reid, Lara Lusa, Emilio breast cancer Bajetta, Luigi Celio, Marco Greco, Alessandra Fabbri, Marco A Pierotti & Maria Grazia Daidone Estrogen signaling ability in human Mitsuyo Matsumoto, Yuri Yamaguchi, 451–463 endometrial cancer through the Yuko Seino, Atsushi Hatakeyama, cancer–stromal interaction Hiroyuki Takei, Hitoshi Niikura, Kiyoshi Ito, Takashi Suzuki, Hironobu Sasano, Nobuo Yaegashi & Shin-ichi Hayashi Expression of progesterone and estradiol Patricia de Cremoux, Dan Rosenberg, 465–474 receptors in normal adrenal cortex, Jacques Goussard, Catherine adrenocortical tumors, and primary ´ ´ ´ Bremont-Weil, Frederique Tissier, pigmented nodular adrenocortical Carine Tran-Perennou, Lionnel disease ´ ˆ Groussin, Xavier Bertagna, Jerome Bertherat & Marie-Laure Raffin-Sanson www.endocrinology-journals.org
  15. 15. Estrogen promotes tumor progression in a Zane Hammoud, Bailin Tan, 475–483 genetically defined mouse model of lung Sunil Badve & Robert M Bigsby adenocarcinoma Endogenous sex hormones and endometrial Naomi E Allen, Timothy J Key, 485–497 cancer risk in women in the European Laure Dossus, Sabina Rinaldi, Prospective Investigation into Cancer and Anne Cust, Annekatrin Lukanova, Nutrition (EPIC) Petra H Peeters, N Charlotte Onland-Moret, Petra H Lahmann, Franco Berrino, Salvatore Panico, ˜ Nerea Larranaga, Guillem Pera, ´ Maria-Jose Tormo, Maria-Jose ´ ´ ´ ´ Sanchez, J Ramon Quiros, Eva Ardanaz, Anne Tjønneland, Anja Olsen, Jenny Chang-Claude, Jakob Linseisen, Mandy Schulz, Heiner Boeing, Eva Lundin, Domenico Palli, Kim Overvad, Francoise Clavel-Chapelon, ¸ Marie-Christine Boutron-Ruault, Sheila Bingham, Kay-Tee Khaw, H Bas Bueno-de-Mesquita, Antonia Trichopoulou, Dimitiros Trichopoulos, Androniki Naska, Rosario Tumino, Elio Riboli & Rudolf Kaaks Cytotoxic effects of a novel M Celano, S Schenone, D Cosco, 499–510 pyrazolopyrimidine derivative entrapped in M Navarra, E Puxeddu, liposomes in anaplastic thyroid cancer cells L Racanicchi, C Brullo, E Varano, in vitro and in xenograft tumors in vivo S Alcaro, E Ferretti, G Botta, S Filetti, M Fresta, M Botta & D Russo BRAFV600E mutation, but not RET/PTC Cristina Romei, Raffaele Ciampi, 511–520 rearrangements, is correlated with a lower Pinuccia Faviana, Laura Agate, expression of both thyroperoxidase and Eleonora Molinaro, Valeria Bottici, sodium iodide symporter genes in papillary Fulvio Basolo, Paolo Miccoli, thyroid cancer Furio Pacini, Aldo Pinchera & Rossella Elisei Interactions between sphingosine-1- Sonja Balthasar, Nina Bergelin, 521–534 phosphate and vascular endothelial growth ¨ Christoffer Lof, Minna Vainio, factor signalling in ML-1 follicular thyroid ¨ Sture Andersson & Kid Tornquist carcinoma cells Regulation of tumor necrosis factor-related Hai-Yan Zhang, Hua-Qin Wang, 535–544 apoptosis-inducing ligand-induced Hai-Mei Liu, Yifu Guan & apoptosis by DJ-1 in thyroid cancer cells Zhen-Xian Du www.endocrinology-journals.org
  16. 16. Peroxisome proliferator-activated receptor D Bonofiglio, H Qi, S Gabriele, 545–557 g inhibits follicular and anaplastic thyroid S Catalano, S Aquila, M Belmonte carcinoma cells growth by upregulating & S Ando ` p21Cip1/WAF1 gene in a Sp1-dependent manner Effects of the Aurora kinase inhibitor VX- Yannick Arlot-Bonnemains, 559–568 680 on anaplastic thyroid cancer-derived Enke Baldini, Benedicte Martin, cell lines Jean-Guy Delcros, Matteo Toller, Francesco Curcio, Francesco S Ambesi-Impiombato, Massimino D’Armiento & Salvatore Ulisse Amyloid precursor-like protein 1 is Yvonne Arvidsson, Ellinor Andersson, 569–581 differentially upregulated in ¨ Anders Bergstrom, Mattias K neuroendocrine tumours of the ¨ Andersson, Gulay Altiparmak, gastrointestinal tract ˚ Ann-Christin Illerskog, Hakan Ahlman, Darima Lamazhapova & Ola Nilsson Efficacy of a dopamine–somatostatin Tullio Florio, Federica Barbieri, 583–596 chimeric molecule, BIM-23A760, in the Renato Spaziante, Gianluigi Zona, control of cell growth from primary cultures Leo J Hofland, Peter M van of human non-functioning pituitary Koetsveld, Richard A Feelders, adenomas: a multi-center study ¨ Gunter K Stalla, Marily Theodoropoulou, Michael D Culler, Jesse Dong, John E Taylor, Jacques- Pierre Moreau, Alexandru Saveanu, Ginette Gunz, Henry Dufour & Philippe Jaquet Predicting values of lipids and white blood Xilin Yang, Wing-Yee So, Ronald 597–607 cell count for all-site cancer in type 2 C W Ma, Gary T C Ko, Alice diabetes P S Kong, Qingsheng Wang, Clive S Cockram, Chun-Chung Chow, Juliana C N Chan & Peter C Y Tong Methylation of the p16INK4A promoter is N B Kiss, J Geli, F Lundberg, C Avci, 609–621 associated with malignant behavior in D Velazquez-Fernandez, J Hashemi, abdominal extra-adrenal paragangliomas ¨¨ ¨ G Weber, A Hoog, T J Ekstrom, but not pheochromocytomas ¨ M Backdahl & C Larsson Mitotane increases the radiotherapy L Cerquetti, B Bucci, R Marchese, 623–634 inhibitory effect and induces G2-arrest in S Misiti, U De Paula, R Miceli, combined treatment on both H295R and A Muleti, D Amendola, P Piergrossi, SW13 adrenocortical cell lines E Brunetti, V Toscano & A Stigliano Targeted therapy for adrenocortical tumors Susanna Vuorenoja, Adolfo 635–648 in transgenic mice through their LH ¨ Rivero-Muller, Adam J Ziecik, receptor by Hecate-human chorionic Ilpo Huhtaniemi, Jorma Toppari & gonadotropin b conjugate Nafis A Rahman www.endocrinology-journals.org
  17. 17. Announcements Author Guidelines Number 3 $ September 2008 Endocrine disruptors and prostate cancer Gail S Prins 649–656 risk Integrins in prostate cancer progression Hira Lal Goel, Jing Li, 657–664 Sophia Kogan & Lucia R Languino Design and validation of specific inhibitors Joanna M Day, Helena J Tutill, 665–692 of 17b-hydroxysteroid dehydrogenases for Atul Purohit and Michael J Reed therapeutic application in breast and prostate cancer, and in endometriosis Medical treatment as an alternative to Asterios Karagiannis, Konstantinos 693–700 adrenalectomy in patients with aldosterone- Tziomalos, Anna I Kakafika, producing adenomas Vasilios G Athyros, Faidon Harsoulis & Dimitri P Mikhailidis Somatostatin analogues in the control of Simona Grozinsky-Glasberg, 701–720 neuroendocrine tumours: efficacy and ´ Ilan Shimon, Marta Korbonits & mechanisms Ashley B Grossman Pituitary tumor-transforming gene in Fateme Salehi, Kalman Kovacs, 721–743 endocrine and other neoplasms: a review Bernd W Scheithauer, Ricardo V Lloyd and update & Michael Cusimano Cyclooxygenase-2 predicts adverse effects Mary F Dillon, Anthony T Stafford, 745–753 of tamoxifen: a possible mechanism of role Gabrielle Kelly, Aisling M Redmond, for nuclear HER2 in breast cancer patients Marie McIlroy, Thomas B Crotty, E McDermott, Arnold D Hill & Leonie S Young Low phosphorylation of estrogen receptor a Hiroko Yamashita, Mariko Nishio, 755–763 (ERa) serine 118 and high phosphorylation Tatsuya Toyama, Hiroshi Sugiura, of ERa serine 167 improve survival in ER- Naoto Kondo, Shunzo Kobayashi, positive breast cancer Yoshitaka Fujii & Hirotaka Iwase Downregulation of Aurora-A overrides Heng Hong Lee, Yansong Zhu, 765–775 estrogen-mediated growth and Karthik M Govindasamy & Ganesan chemoresistance in breast cancer cells Gopalan www.endocrinology-journals.org
  18. 18. Evaluation of a functional epigenetic Caroline D E Margetts, Mark Morris, 777–786 approach to identify promoter region Dewi Astuti, Dean C Gentle, methylation in phaeochromocytoma and Alberto Cascon, Fiona E McRonald, neuroblastoma Daniel Catchpoole, Mercedes Robledo, Hartmut P H Neumann, Farida Latif & Eamonn R Maher Re-expression of ABI3-binding protein Flavia R M Latini, 787–799 suppresses thyroid tumor growth by Jefferson P Hemerly, Gisele Oler, promoting senescence and inhibiting Gregory J Riggins & Janete M Cerutti invasion Array-CGH identifies cyclin D1 and Jia-Jing Lee, Amy Y M Au, 801–815 UBCH10 amplicons in anaplastic thyroid Theodoros Foukakis, Michela Barbaro, carcinoma Nimrod Kiss, Roderick Clifton-Bligh, ˚ Johan Staaf, Ake Borg, Leigh Delbridge, Bruce G Robinson, ¨ ¨¨ Goran Wallin, Anders Hoog & Catharina Larsson Oct-1 induces pituitary tumor transforming Cuiqi Zhou, Yunguang Tong, 817–831 gene expression in endocrine tumors Kolja Wawrowsky, Serguei Bannykh, Ines Donangelo & Shlomo Melmed Metformin attenuates the stimulatory effect Carolyn Algire, Mahvash Zakikhani, 833–839 of a high-energy diet on in vivo LLC1 Marie-Jose Blouin, Jian Hua Shuai carcinoma growth & Michael Pollak Announcements Author Guidelines Number 4 $ December 2007 Androgen receptor and growth factor Meng-Lei Zhu & Natasha Kyprianou 841–849 signaling cross-talk in prostate cancer cells Implications of the binding of tamoxifen to Douglas J Kojetin, Thomas P Burris, 851–870 the coactivator recognition site of the Elwood V Jensen & Sohaib A Khan estrogen receptor The genetic basis of hereditary medullary George H Sakorafas, Helmut Friess 871–884 thyroid cancer: clinical implications for the & George Peros surgeon, with a particular emphasis on the role of prophylactic thyroidectomy www.endocrinology-journals.org
  19. 19. The diagnosis and management of Gregory A Kaltsas, Jane Evanson, 885–903 parasellar tumours of the pituitary Alexandra Chrisoulidou & Ashley B Grossman Medical therapy for clinically non- Annamaria Colao, Carolina Di 905–915 functioning pituitary adenomas Somma, Rosario Pivonello, Antongiulio Faggiano, Gaetano Lombardi & Silvia Savastano Forkhead box-O transcription factor: Carl Weidinger, Kerstin Krause, 917–929 critical conductors of cancer’s fate Antje Klagge, Stefan Karger & Dagmar Fuhrer Reapprasial of the role of endocrine therapy ´ Cyrus Chargari, Lionel Vedrine, 931–941 in meningioma management Oliver Bauduceau, Sylvestre Le Moulec, Bernard Ceccaldi & Nicolas Magne´ Bone mineral density in Japanese prostate Wei Wang, Takeshi Yuasa, Norihiko 943–952 cancer patients under androgen-deprivation Tsuchiya, Shinya Maita, Teruaki therapy Kumazawa, Takamitsu Inoue, Mitsuru Saito, Zhiyong Ma, Takashi Obara, Hiroshi Tsuruta, Shigeru Satoh & Tomonori Habuchi Calcitonin promotes in vivo metastasis of Girish V Shah, Shibu Thomas, 953–964 prostate cancer cells by altering cell Anbalagan Muralidharan, Yong Liu, signaling, adhesion, and inflammatory Paul L Hermonat, Jill Williams & pathways Jaideep Chaudhary The anandamide analog, Met-F-AEA, Chiara Laezza, Simona Pisanti, 965–974 controls human breast cancer cell migration Anna Maria Malfitano & via the RHOA/RHO kinase signaling Maurizio Bifulco pathway Vitamin D receptor polymorphisms (FokI, Marc Sinotte, Francois Rousseau, ¸ 975–983 BsmI) and breast cancer risk: association Pierre Ayotte, Eric Dewailly, replication in two case–control studies ` Caroline Diorio, Yves Giguere, within French Canadian population ´ rube & Jacques Brisson Sylvie Be ´ ERBB2 influences the subcellular Sunil Pancholi, Anne E Lykkesfeldt, 985–1002 localization of the estrogen receptor in Caroline Hilmi, Susana Banerjee, tamoxifen-resistant MCF-7 cells leading to Alexandra Leary, Suzanne Drury, the activation of AKT and RPS6KA2 Stephen Johnston, Mitch Dowsett & Lesley-Ann Martin Signaling pathways involved in the O Arroyo-Helguera, E Rojas, 1003–1011 antiproliferative effect of molecular iodine G Delgado & C Aceves in normal and tumoral breast cells: evidence that 6-iodolactone mediates apoptotic effects www.endocrinology-journals.org
  20. 20. Adenomatous polyposis coli alteration in Silvia Pizzi, Cinzia Azzoni, Elisa 1013–1024 digestive endocrine tumours: correlation Tamburini, Lorena Bottarelli, with nuclear translocation of b-catenin and Nicoletta Campanini, Tiziana D’Adda, chromosomal instability Giovanni Fellegara, Tu Vinh Luong, Claudio Pasquali, Giulio Rossi, Gianfranco Delle Fave, Roberta Camisa, Cesare Bordi & Guido Rindi Ectopic expression of serotonin7 receptors E Louiset, K Isvi, J M Gasc, 1025–1034 in an adrenocortical carcinoma co-secreting ` C Duparc, B Cauliez, A Laquerriere, renin and cortisol J M Kuhn & H Lefebvre I Age-related neoplastic risk profiles and Ioana N Milos, Karin Frank-Raue, 1035–1041 penetrance estimations in multiple Nelson Wohllk, Ana Luiza Maia, endocrine neoplasia type 2A caused by Eduardo Pusiol, Attila Patocs, germ line RET Cys634Trp (TGCOTGG) Mercedes Robledo, Josefina Biarnes, mutation Marta Barontini, Thera P Links, Jan Willem de Groot, Sarka Dvorakova, Mariola Peczkowska, Lisa A Rybicki, Maren Sullivan, Friedhelm Raue, Ioana Zosin, Charis Eng & Hartmut P H Neumann Prospective evaluation of mitotane toxicity Fulvia Daffara, Silvia De Francia, 1043–1053 in adrenocortical cancer patients treated Giuseppe Reimondo, Barbara Zaggia, adjuvantly Emiliano Aroasio, Francesco Porpiglia, Marco Volante, Angela Termine, Francesco Di Carlo, Luigi Dogliotti, Alberto Angeli, Alfredo Berruti & Massimo Terzolo Association of two common single- Marc T Goodman, Galina Lurie, 1055–1060 nucleotide polymorphisms in the CYP19A1 Pamela J Thompson, Katharine locus and ovarian cancer risk E McDuffie & Michael E Carney Epithelial ovarian cancer: testing the ` Catherine M Olsen, Adele C Green, Christina 1061–1068 ‘androgens hypothesis’ M Nagle, Susan J Jordan, David C Whiteman, Christopher J Bain & Penelope M Webb on behalf of the Australian Cancer Study Group (Ovarian Cancer) and the Australian Ovarian Cancer Study Group Increased density of tumor-associated Mabel Ryder, Ronald A Ghossein, 1069–1074 macrophages is associated with decreased Julio C M Ricarte-Filho, survival in advanced thyroid cancer Jeffrey A Knauf & James A Fagin Familial non-medullary thyroid carcinoma M Capezzone, S Marchisotta, 1075–1081 displays the features of clinical anticipation S Cantara, G Busonero, L Brilli, suggestive of a distinct biological entity K Pazaitou-Panayiotou, A F Carli, G Caruso, P Toti, S Capitani, A Pammolli & F Pacini www.endocrinology-journals.org
  21. 21. Prognostic factors of long-term outcome in Ulrich-Frank Pape, Uta Berndt, 1083–1097 gastroenteropancreatic neuroendocrine ¨ Jacqueline Muller-Nordhorn, tumours ¨ Michael Bohmig, Stephanie Roll, Martin Koch, Stefan N Willich & Bertram Wiedenmann Protein western array analysis in human ˆ Antonio Ribeiro-Oliveira Jr, 1099–1114 pituitary tumours: insights and limitations Giulia Franchi, Blerina Kola, ´ Paolo Dalino, Sergio Veloso Brant Pinheiro, Nabila Salahuddin, ´ ´ Madalina Musat, Miklos I Goth, ´ ´ ´ ´ Sandor Czirjak, Zoltan Hanzely, Deivid Augusto da Silva, Eduardo Paulino Jr, ´ Ashley B Grossman & Marta Korbonits Clinical, genetic, and histopathologic Giulia Masi, Luisa Barzon, 1115–1126 investigation of CDC73-related familial Maurizio Iacobone, Giovanni Viel, hyperparathyroidism Andrea Porzionato, Veronica Macchi, Raffaele De Caro, Gennaro Favia & ` Giorgio Palu Metastases but not cardiovascular mortality H J L M Timmers, F M Brouwers, 1127–1133 reduces life expectancy following surgical A R M M Hermus, F C G J Sweep, resection of apparently benign A A J Verhofstad, A L M Verbeek, pheochromocytoma K Pacak & J W M Lenders Announcements Author Guidelines Volume Contents www.endocrinology-journals.org

×